Sangro B, Melero I, Yau T, et al. Nivolumab in Sorafenib-Naive and -Experienced Patients With Advanced Hepatocellular Carcinoma (HCC): Survival, Hepatic Safety, and Biomarker Assessments in CheckMate 040. AAASLD 2017, Presidential Poster of Distinction 141.
Risico op psoriasis na behandeling met een TNF-α-remmer
jul 2022 | IBD, Psoriasis, Reumatoïde artritis